Subcutaneous apomorphine in the treatment of Parkinson's disease.

Apomorphine a dopamine receptor agonist was given subcutaneously to 57 levodopa treated parkinsonian patients with refractory off-period disabilities for a median period of 16 months. In 30 given intermittent suprathreshold injections the mean number of hours spent in a disabling off state fell from...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Neurol Neurosurg Psychiatry
Principais autores:	Frankel, J P, Lees, A J, Kempster, P A, Stern, G M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC487943/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2313313/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.53.2.96
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!